SECreport

Form 4 TherapeuticsMD, Inc. For: Aug 28 Filed by: Donegan Michael C

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com